Recent reports have been surfacing in regard to adverse reactions in dermal fillers patients who have also received the COVID-19 vaccine. Whitney Bowe, MD, New York City, New York, discusses this phenomenon and provides some tips for preventing and treating these side effects.
Esther Freeman, MD, PhD, details how her and her fellow colleagues banded together to create a COVID-19 dermatology registry in just eight days. The registry has since seen over 1,000 submissions from frontline clinicians located in 40 countries, helping to identify and diagnose active COVID-19 through submitted skin findings.
Since the start of the pandemic, there has been a rise in dermatoses in healthcare workers related to occupational use of personal protective equipment (PPE). Rachel Evers-Meltzer, MD, MPH, discusses her cross-sectional survey investigating what types of dermatoses were most commonly seen in the health care spear and suggests possible treatments.
The aesthetics industry saw a massive boom during the COVID-19 pandemic for both invasive and non-invasive procedures. Amir Karam, M.D., San Diego, Calif., reveals what caused this increase in demand for aesthetics procedures and discusses the outlook for the future of the industry.
The potential for antibiotic resistance have caused some physicians to be wary of the drug class when prescribing an acne treatment regimen. Christopher Bunick, M.D., Ph.D., clears the air around antibiotic use for acne and discusses his research of narrow-spectrum antibiotics.
Neelam Vashi, M.D., FAAD, discusses the publication of her cross-sectional survey in the Journal of the American Academy of Dermatology regarding how different racial and ethnic groups possess various levels of melanoma awareness.
Amir Karam, M.D., facial plastic surgeon, San Diego, Calif., explains the rising incidences of acne associated with face mask usage, otherwise known as maskne, as well as tips for prevention and treatment.
Michael Sherling, M.D., practicing dermatologist and chief medical and strategy officer at Modernizing Medicine, discusses the recent rise in telemedicine use in dermatology, the benefits and detriments, as well as the future for the industry.
Media expert Paige Velasquez Budde, CEO of Zilker Media, explains the importance of building a brand as a physician, as well as some mistakes to avoid and tips on how to grow and shape your brand.
In this episode, Candrice Heath, M.D., sits down to discuss her recent presentation at the 2020 Skin of Color Update about clinical pearls for kids, tweens and teens with skin of color. Dr. Heath also explains the most common skin conditions for this patient group, treatment challenges, and much more.
In this episode, UIC medical students Kayla Clark and Gina Alvarado Jones, along with UIC Dermatology Department Head Maria Tsoukas, M.D. Ph.D., discuss their recently published analysis in JAAD, which takes a look at skin of color representation in medical education.
This episode discusses how to become a pediatric dermatologist, including the associated benefits, compensation and responsibilities with Heather Brandling-Bennett, M.D.
This episode dives into emerging research regarding probiotics specifically tailored to treat psoriasis and possibly other inflammatory skin diseases.
This episode discusses a recent survey conducted by the International Society of Dermatology’s Climate Change Committee involving climate change and its effect on skin diseases throughout the world with one of its committee members, Sarah Coates, M.D.
With summer in full swing, this episode takes a look at how social media can influence sun protection use in teens and young adults, and why certain ingredients in sunscreens are considered controversial.
In our first episode of The Cutaneous Connection, Adam Friedman, M.D., FAAD, discusses his recent presentation at the first virtual American Academy of Dermatology meeting about cannabinoids use in dermatology.
Dermatology Times talked with several experts over the course of the Fall Clinical Dermatology meeting to glean practical insights from their presentations.
Our Dermatology Times reporter gleans takeaways from several experts who spoke at the summer meeting of the American Academy of Dermatology.
Dr. Jim Leyden, an active participant in isotretinoin's drug development process, discusses many of the important initial clinical observations and those that others have made over the years.
In part three of our discussion about pediatric dermatology, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses screening labs, avoiding complacency, and the ABCDEs of melanoma with Dermatology Times editorial advisor, Elaine Siegfried, M.D.
In part two of our discussion, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses environmental and microbial triggers and when to choose systemic therapies with Dermatology Times editorial advisor, Elaine Siegfried, M.D.
